Background: The most common aetiology of cardiogenic shock (CS) is acute coro-
| INTRODUC TI ON
An electrocardiogram (ECG) is one of the easiest attainable clinical tools in cardiogenic shock (CS). Often, the diagnosis of CS is apparent, but the aetiology usually emerges only after performing further diagnostic measures, such as echocardiography and invasive examination. CS is most often caused by acute coronary syndrome (ACS; Harjola et al., 2015; Hochman et al., 2000) ; however, in up to 50% of the cases, the aetiology is other than ACS (Shah et al., 2017) . The other causes include for example the exacerbation of chronic heart failure, myocarditis and structural disorders (Gowda, Fox, & Khan, 2008) . In ACS, ST-segment changes are a usual finding in the ECG. However, ST-segment deviations can also have other causes. For example, ST-segment elevations (STE) can be present in myocarditis (Caforio, Marcolongo, Basso, & Iliceto, 2015) or in stress-induced cardiomyopathy (Auzel et al., 2016) , while ST-segment depressions (STDEP) can be the result of the chronic changes caused by left ventricular hypertrophy (Schocken, 2014) .
Regardless of the development of CS treatment strategies, the mortality is still extremely high, with a rate of up to 50% (Jeger et al.., 2008; Kolte et al., 2014 ). An ECG is one of the first tools that can be used in the clinical evaluation of CS. However, there is no data in the current literature concerning ST-segment deviations in patients with different CS aetiologies. Previously, STsegment deviations have only been investigated in patients with ACS aetiology, excluding the patients with other CS aetiologies.
Furthermore, the results of the earlier studies are inconsistent in ACS-related CS; some have suggested a higher mortality in patients with non-STE myocardial infarction (NSTEMI; Anderson et al., 2013; Holmes et al., 1999; Jeger et al., 2008) , while others have found no differences in the mortality (Jacobs et al., 2000; Jakl et al., 2014) .
The aim of the present study was to examine the prevalence of ST-segment patterns and their association with the CS aetiology, clinical findings and 90-day mortality. Second, we conducted a subgroup analysis of those patients with ACS aetiology and compared the ST-segment patterns with the angiographic findings and 90-day mortality.
| ME THODS

| Study population
The CardShock Study (NCT01374867 at www.clinicaltrials.gov) is a prospective multinational study of CS conducted at nine centres in eight countries between October 2010 and December 2012. A more detailed description of the study protocol has been reported previously (Harjola et al., 2015) . Briefly, the study enrolled consecutive patients over 18 years of age within 6 hr after the detection of CS. The criteria for shock were a systolic blood pressure <90 mmHg for 30 min, despite adequate fluid therapy or a need for vasoactive therapy, and ≥1 sign of inadequate organ perfusion (confusion or an altered mental status, cool extremities, oliguria <0.5 ml kg −1 hr −1 for the previous 6 hr or blood lactate >2 mmol/L).
The patients with ongoing hemodynamically significant arrhythmias and shock after cardiac or non-cardiac surgery were excluded. Written informed consent was obtained from each patient or the next of kin.
The patients' characteristic and comprehensive medical history were collected. The clinical signs and the laboratory measurements were registered at the baseline and at various time points. In this study, the laboratory results were analysed at the baseline. The creatinine, C-reactive protein (CRP), high sensitivity troponin T (hs-TnT) and N-terminal pro B-type natriuretic peptide (NT-proBNP; Roche Diagnostics, Basel, Switzerland) were analysed centrally from blood samples stored at −80°C. The arterial blood lactate and pH were analysed locally. The estimated glomerular filtration rate (eGFR) was calculated from the creatinine values using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. An echocardiogram was performed per protocol upon entry into the study.
The patients were treated according to local practice in each centre, and the treatments and procedures provided were registered. Detailed coronary angiography information was collected.
The local investigators determined the CS aetiology. ACS aetiology included STE myocardial infarction (STEMI) and NSTEMI. A subgroup analysis of the patients with ACS aetiology was conducted.
The endpoint of this study was the all-cause mortality at the 90-day follow-up. The vital status was confirmed by the patient or the next of kin, or through the hospital or population registers. This study was approved by the local ethics committees and conducted in accordance with the Declaration of Helsinki.
| ECG analysis
The ECGs included in this study were obtained at the point of study inclusion in each participating centre. All the ECGs were sent either in electronic or paper formats to the core laboratory in Helsinki, where the electronic ECGs were printed out. The ECGs were analysed by one examiner (cardiology resident HT) with custom-made non-commercial software engineered for ECG analysis at the University of Helsinki. Briefly, the digitisation process for this software was as follows. First, the ECGs were scaled to have the same calibration for paper speed (50 mm/s) and voltage (1 mV/10 mm).
Then, the examiner defined the baseline of the ECG at the level of the PQ interval and all the key points in each ECG manually: the start and end points of the P wave, each component of the QRS-complex individually, the J point and the ST-segment at 0.04 and 0.08 s after the J point, and the start, peak and end points of the T-wave. Two consecutive beats were analysed. Finally, the software calculated the time intervals between these specified ECG points and the voltage differences between the specified points and the ECG baseline.
The mean values of the results from the two consecutive beats were used in the analyses.
The ST-segment analysis for the STE was conducted at the J point and for the STDEP at the J point and 0.04 s after the J point (Thygesen et al., 2012 (Thygesen et al., 2012) .
2. STDEP group: a horizontal or down-sloping STDEP ≥ 0.05 mV in two contiguous leads (Thygesen et al., 2012) . The patients with both an STE and STDEP were included in the STE group. In the STE patients, the STE localisation was assessed.
Contiguous leads refer to the anterior leads (V 1 -V 4 ), inferior leads (II, III and aVF) or lateral leads (I, aVL and V 5 -V 6 ).
| Statistical analysis
The categorical variables are presented as numbers (n) and percentages (%), and the continuous variables as means with standard deviations (SD) or medians with interquartile ranges (IQR). The categorical variables were analysed using a chi-squared test or Fisher's exact test when they were binominal, and with a logistic regression when they were multinomial. 
| RE SULTS
| Electrocardiographic data and baseline characteristics
The CardShock study included 219 patients and the baseline ECG was available for 198 patients. Two ECGs were excluded because they presented idioventricular rhythm. Finally, 196 patients were included in this substudy. ST-segment deviations were observed in 80% of the ECGs (n = 157): STE was present in 52% (n = 101) and STDEP in 29% (n = 56) ( Figure 1a ). The STE localisation was anterior in 51% (n = 52), inferior in 36% (n = 36) and lateral in 13% (n = 13). In the NSTD group, the most common finding was LBBB (n = 10, 5.1%).
The other findings were Q waves (n = 7, 3.6%) and T wave inversions (n = 6, 3.1%) without ST-segment deviation. A ventricular paced rhythm was found in 3 patients (1.5%).
The mean age of the patients was 66 years old (SD 12), and 74%
were male. Table 1 displays the baseline characteristics of the patients. Briefly, there were no differences in the age, gender or body mass index between the study groups. The STE patients had less comorbidities in comparison with the other two groups, but they were more often smokers. The STE patients had higher hs-TnT values than the patients in the other two groups, but there were no differences in the NT-proBNP values or in the routine laboratory test results.
| CS aetiology
Acute coronary syndrome was the cause of CS in 81% (n = 159) of the patients. The patients in the STE group had ACS (93%) more often, when compared to the STDEP group (73%, p < 0.01) and NSTD group (62%, p < 0.01) (Figure 1b) . The most common non-ACS aetiology was the exacerbation of chronic heart failure (n = 21, 11%); the other causes were valvular disorders, stress-induced cardiomyopathy and myocarditis (Table 1) .
| Mortality
The overall 90-day mortality rate was 41% (n = 80), and there were no significant differences between the mortality rates in the different ST-segment pattern groups (STE 47%, STDEP 36% and NSTD 33%, p = 0.15, Figure 2a ). In the univariate mortality analysis, none of the ST-segment patterns were associated with mortality, but after the adjustment, STE was associated with an increased 90-day mortality (HR 1.74, 95% CI 1.07-2.84, p = 0.03, Table 2A ). The other independent predictors of the 90-day mortality were age, LVEF, arterial blood lactate, systolic blood pressure and coronary artery disease history (Table 2A) . STDEP or NSTD did not have prognostic value (Table 2A) .
The ACS patients tended to have higher mortality than the non-ACS patients (43% vs. 30%, p = 0.09). Within the STE group, an inferior STE had a lower 90-day mortality rate in comparison with anterior STE (Figure 2b ). It was also associated with a lower mortality in the univariate analysis (HR 0.21, 95% CI 0.21-0.83, p = 0.01), but not in the multivariate analysis (HR 0.58, 95% CI 0.26-1.27 p = 0.17).
| Acute coronary syndrome subgroup analysis
The ACS subgroup consisted of 159 patients. Coronary angiography was performed in 94% (n = 150) of the patients, and almost all of the patients were treated with PCI (STE 92%, STDEP 87% and NSTD 86%, p = 0.48). The rate of successful revascularization (TIMI 3) was similar in all the study groups (Table 1) . A majority of the patients had multivessel coronary artery disease, but the STE patients had less 3-vessel disease when compared with the STDEP patients (24% vs. 42% p = 0.04).
In the ACS subgroup, the 90-day mortality rate was 43% (STE 47%, STDEP 42% and NSTD 33%, p = 0.31, Figure 2c ). In the univariate and multivariate analyses, the ST-segment patterns were not associated with the 90-day mortality. The independent predictors were the LVEF, systolic blood pressure and arterial blood lactate (Table 2B) . The percentages were calculated in the patients who underwent coronary angiography.
| D ISCUSS I ON
TA B L E 1 (Continued)
aetiology and 90-day mortality in the unselected CS population.
While ACS was the most common finding in all the study groups, onethird of the patients without STE had aetiology other than ACS. In the ACS subgroup, the effective revascularization rates were similar, and no differences in the survival were noted between the study groups.
In this study, the majority of the patients had ST-segment de-
viations. An STE was the most common finding, and it was almost always discovered in the ACS patients. The prevalence of the ST-segment changes in CS has not been evaluated before, but in studies concerning ACS, the incidence of CS in STEMI has been two to three times higher in comparison with NSTEMI (Anderson et al., 2013; Holmes et al., 1999; Jeger et al., 2008) . The STE lo- In CS, an STDEP in the baseline ECG is usually suggestive of subendocardial ischaemia. However, the present study shows that in CS, one-fourth of the STDEP patients had aetiology other than ACS.
The aetiology of CS in the STDEP patients was the most diverse, as these patients presented with all the different aetiologies recorded in our study. Even though ACS was the most common reason for the STDEP, the other aetiologies cannot be neglected in the differential diagnosis, especially in the early phases of the treatment. However, over half of the patients without interpretable ST-segment deviations had ACS aetiology. A reminder that even in ACS-related CS,
ST-segment deviations may not be present. To summarize, one-third of the patients without STE had CS aetiology other than ACS, a significant minority that must be taken into account in the management of CS.
Our results add, that in CS patients presenting with STE, CS could be the first manifestation of coronary artery disease, and smoking was one of the imposing risk factors. The STE patients also tended to be younger when compared with the STDEP patients. These findings are in line with the previous CS studies describing the STEMI patients as younger, more often male and having less comorbidities than the NSTEMI patients (Anderson et al., 2013; Holmes et al., 1999; Jacobs et al., 2000) . The STE patients had high hs-TnT levels, suggesting a large myocardial damage, as depicted in previous studies (Chia et al., 2008) . The LVEF and NT-proBNP levels were equal in all the groups, implying that the heart failure severity cannot be predicted by ST-segment deviations in CS.
In the ACS subgroup analysis, the rate of successful revascularization was similar, regardless of the ST-segment pattern,
indicating that the ACS patients were treated according to the contemporary guidelines (McMurray et al., 2012) . In the previous studies concerning ACS-related CS, the coronary angiography rates (41%-72%) and especially the PCI rates (13%-72%) have been lower in the patients with NSTEMI (Anderson et al., 2013; Holmes et al., 1999; Jacobs et al., 2000; Jeger et al., 2008; Kolte et al., 2014) . This difference may be explained by the fact that some of the previous studies were conducted at the turn of the 21st century (Holmes et al., 1999; Jacobs et al., 2000) . The more contemporary ones were registry or database studies, which could reflect the differences in the treatment strategies and the results when compared to our prospective study (Anderson et al., 2013; Jeger et al., 2008; Kolte et al., 2014) . We found that the majority of the patients had multivessel disease, which was TA B L E 2 The multivariate regression analysis for the 90-day mortality (A) in the entire study cohort and (B) in the ACS subgroup also true in the STE group. This finding is in accordance with earlier studies, as greater burden of coronary artery disease has been associated with an increased risk of CS in STEMI patients (Obling et al., 2017 ). An STDEP was associated with three-vessel disease, as previously depicted (Anderson et al., 2013; Holmes et al., 1999; Jacobs et al., 2000; Jakl et al., 2014) , but the prevalence of the left main coronary artery disease was similar in the STE and STDEP groups, in contrast to earlier studies (Jacobs et al., 2000) .
We found that an STE in the baseline ECG was associated with increased mortality in the unselected CS population. This finding probably reflects the fact that an STE was strongly correlated with an ACS aetiology, and the mortality rates tended to be higher in those patients with ACS. Within the STE group, the patients with inferior STE had the lowest mortality in CS, as reported previously in ACS (Haim et al., 1997; Thanavaro et al., 1982) but not in CS (White et al., 2004) . The better prognosis of an inferior STE probably relates to the culprit artery being the right coronary artery, which has been associated with better survival in CS (Trzeciak et al., 2013; Wong et al., 2000) .
In the ACS subgroup analysis, the ST-segment deviations were not associated with mortality, corresponding to some earlier studies (Jacobs et al., 2000; Jakl et al., 2014) . However, the previous data is inconsistent; some contemporary studies have reported opposite results, where the prognosis of NSTEMI has been inferior to the prognosis of STEMI (Anderson et al., 2013; Jeger et al., 2008) .
Essentially, a comparison of the outcomes of these studies is difficult, because there are many factors contributing to the survival of CS patients. However, one major difference can be noted. In the present study, almost all of the patients were revascularized, whereas in the previous studies, the rate of revascularization was significantly lower in the NSTEMI patients when compared to the STEMI patients. Consequently, we believe that the equal survival rates of the NSTEMI and STEMI patients observed in this study may reflect the effective revascularization of all the ACS patients. This emphasizes the importance of an emergent invasive evaluation and treatment of all CS patients, regardless of the ST-segment pattern, as stated in the guidelines (Amsterdam et al., 2014; O'Gara et al., 2012; Ponikowski et al., 2016) .
In this study, certain limitations should be recognized. First, it is essential to acknowledge the dynamic nature of an ECG, especially in the context of ACS, in which changes in myocardial ischaemia can affect the ST-segment levels within minutes. However, we believe that our study reflects acute clinical practice well, where decision-making is based on the baseline rather than on serial ECGs. Another limitation is that the patient numbers in the STDEP and NSTD groups were low. However, this is the only study thus far describing ST-segment deviations in CS patients with various aetiologies.
In conclusion, almost all the CS patients present with ST-segment deviations in their baseline ECG. An STE is strongly associated with ACS, and it is a marker of high mortality in the patients with various CS aetiologies. An STDEP is an alarm bell for complex comorbidities and for a high burden of coronary artery disease, but also for aetiologies other than ACS. While ACS is the most common CS aetiology in all the ST-segment patterns, one-third of the patients without STE have aetiology other than ACS. When patients with ACS-related CS are equally effectively revascularized, they have similar prognosis, regardless of the ST-segment patterns.
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